The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis-Reference-Cited by-同舟云学术

The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis

Published:2022-10-19 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Nalini Neelam,Kumar Amit,Sharma Saumya,Singh Bijeta,Singh Aditya V,Prakash Jay,Singh Shreshtha

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference66 articles.

1. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths;Siegel R;CA Cancer J Clin,2011

2. The FDA recommends against using screening tests for ovarian cancer screening. FDA safety communication. (2016). https://www.moph.gov.lb/userfiles/files/Medical%20Devices/Medical%20Devices%20Recalls%202016/5-9-2016/OvarianCancerSc....

3. Screening for ovarian cancer: US preventive services task force recommendation statement;Grossman DC;JAMA,2018

4. Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: a meta-analysis;Zhen S;Mol Clin Oncol,2014

5. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass;Moore RG;Gynecol Oncol,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges;Cancers;2023-11-06

2. Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer;Journal of International Medical Research;2023-09

3. Tumor Markers and Their Diagnostic Significance in Ovarian Cancer;Life;2023-08-05